216 related articles for article (PubMed ID: 23086329)
1. Chromoblastomycosis in Mainland China: a systematic review on clinical characteristics.
Lu S; Lu C; Zhang J; Hu Y; Li X; Xi L
Mycopathologia; 2013 Jun; 175(5-6):489-95. PubMed ID: 23086329
[TBL] [Abstract][Full Text] [Related]
2. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
[TBL] [Abstract][Full Text] [Related]
4. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
[TBL] [Abstract][Full Text] [Related]
5. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Yang YP; Li W; Huang WM; Zhou Y; Fan YM
Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
[TBL] [Abstract][Full Text] [Related]
6. Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.
Xi L; Sun J; Lu C; Liu H; Xie Z; Fukushima K; Takizawa K; Najafzadeh MJ; De Hoog GS
Med Mycol; 2009 Feb; 47(1):27-33. PubMed ID: 18951291
[TBL] [Abstract][Full Text] [Related]
7. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
[TBL] [Abstract][Full Text] [Related]
8. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
[TBL] [Abstract][Full Text] [Related]
10. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
11. Chromoblastomycosis caused by Cladophialophora carrionii in a child from India.
Pradeepkumar NS; Joseph NM
J Infect Dev Ctries; 2011 Jul; 5(7):556-60. PubMed ID: 21795827
[TBL] [Abstract][Full Text] [Related]
12. Chromoblastomycosis in India: Review of 169 cases.
Agarwal R; Singh G; Ghosh A; Verma KK; Pandey M; Xess I
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005534. PubMed ID: 28771470
[TBL] [Abstract][Full Text] [Related]
13. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
Fransisca C; He Y; Chen Z; Liu H; Xi L
Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
Guevara A; Nery AF; de Souza Carvalho Melhem M; Bonfietti L; Rodrigues AM; Hagen F; de Carvalho JA; de Camargo ZP; de Souza Lima BJF; Vicente VA; Hahn RC
Mycoses; 2022 Dec; 65(12):1146-1158. PubMed ID: 35869803
[TBL] [Abstract][Full Text] [Related]
16. Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.
Brito AC; Bittencourt MJS
An Bras Dermatol; 2018; 93(4):495-506. PubMed ID: 30066754
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
[TBL] [Abstract][Full Text] [Related]
18. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
[TBL] [Abstract][Full Text] [Related]
19. Lymphangitic chromoblastomycosis.
Muhammed K; Nandakumar G; Asokan KK; Vimi P
Indian J Dermatol Venereol Leprol; 2006; 72(6):443-5. PubMed ID: 17179621
[TBL] [Abstract][Full Text] [Related]
20. Chromoblastomycosis in Latin America and the Caribbean: Epidemiology over the past 50 years.
Guevara A; Siqueira NP; Nery AF; Cavalcante LRDS; Hagen F; Hahn RC
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34637525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
